338 related articles for article (PubMed ID: 31104072)
1. Multimorbidity, polypharmacy and primary prevention in community-dwelling adults in Quebec: a cross-sectional study.
Nguyen TN; Ngangue P; Haggerty J; Bouhali T; Fortin M
Fam Pract; 2019 Nov; 36(6):706-712. PubMed ID: 31104072
[TBL] [Abstract][Full Text] [Related]
2. Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study.
Hanlon P; Nicholl BI; Jani BD; McQueenie R; Lee D; Gallacher KI; Mair FS
BMJ Open; 2018 Jan; 8(1):e018404. PubMed ID: 29332840
[TBL] [Abstract][Full Text] [Related]
3. Late-life depression and the association with multimorbidity and polypharmacy: a cross-sectional study.
Holvast F; van Hattem BA; Sinnige J; Schellevis F; Taxis K; Burger H; Verhaak PFM
Fam Pract; 2017 Sep; 34(5):539-545. PubMed ID: 28369380
[TBL] [Abstract][Full Text] [Related]
4. Burden of multimorbidity and polypharmacy among cancer survivors: a population-based nested case-control study.
Keats MR; Cui Y; DeClercq V; Grandy SA; Sweeney E; Dummer TJB
Support Care Cancer; 2021 Feb; 29(2):713-723. PubMed ID: 32444894
[TBL] [Abstract][Full Text] [Related]
5. Polypharmacy and specific comorbidities in university primary care settings.
Aubert CE; Streit S; Da Costa BR; Collet TH; Cornuz J; Gaspoz JM; Bauer D; Aujesky D; Rodondi N
Eur J Intern Med; 2016 Nov; 35():35-42. PubMed ID: 27289492
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of self-reported multimorbidity in the general population and in primary care practices: a cross-sectional study.
Mokraoui NM; Haggerty J; Almirall J; Fortin M
BMC Res Notes; 2016 Jun; 9():314. PubMed ID: 27315815
[TBL] [Abstract][Full Text] [Related]
7. Cross-sectional analysis of the prevalence and predictors of statin utilisation in Ireland with a focus on primary prevention of cardiovascular disease.
Byrne P; Cullinan J; Murphy C; Smith SM
BMJ Open; 2018 Feb; 8(2):e018524. PubMed ID: 29439070
[TBL] [Abstract][Full Text] [Related]
8. Pill for this and a pill for that: A cross-sectional survey of use and understanding of medication among adults with multimorbidity.
Millar E; Gurney J; Stanley J; Stairmand J; Davies C; Semper K; Dowell A; Lawrenson R; Mangin D; Sarfati D
Australas J Ageing; 2019 Jun; 38(2):91-97. PubMed ID: 30556358
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of and factors associated with multimorbidity among 18 101 adults in the South East Asia Community Observatory Health and Demographic Surveillance System in Malaysia: a population-based, cross-sectional study of the MUTUAL consortium.
Tan MMC; Prina AM; Muniz-Terrera G; Mohan D; Ismail R; Assefa E; Keinert AÁM; Kassim Z; Allotey P; Reidpath D; Su TT
BMJ Open; 2022 Dec; 12(12):e068172. PubMed ID: 36564121
[TBL] [Abstract][Full Text] [Related]
10. Measuring multimorbidity in older adults: comparing different data sources.
Gontijo Guerra S; Berbiche D; Vasiliadis HM
BMC Geriatr; 2019 Jun; 19(1):166. PubMed ID: 31200651
[TBL] [Abstract][Full Text] [Related]
11. Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burden.
Gallacher KI; Batty GD; McLean G; Mercer SW; Guthrie B; May CR; Langhorne P; Mair FS
BMC Med; 2014 Oct; 12():151. PubMed ID: 25280748
[TBL] [Abstract][Full Text] [Related]
12. Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study.
Zhao Y; Wang J; Zhu X; Zhang X; Zhang Y; Zhang W; Dong Y
BMC Geriatr; 2023 Jul; 23(1):423. PubMed ID: 37434147
[TBL] [Abstract][Full Text] [Related]
13. Predicting poorer health outcomes in older community-dwelling patients with multimorbidity: prospective cohort study assessing the accuracy of different multimorbidity definitions.
Sasseville M; Smith SM; Freyne L; McDowell R; Boland F; Fortin M; Wallace E
BMJ Open; 2019 Jan; 9(1):e023919. PubMed ID: 30612111
[TBL] [Abstract][Full Text] [Related]
14. Measuring medication adherence in older community-dwelling patients with multimorbidity.
Kim S; Bennett K; Wallace E; Fahey T; Cahir C
Eur J Clin Pharmacol; 2018 Mar; 74(3):357-364. PubMed ID: 29199370
[TBL] [Abstract][Full Text] [Related]
15. Obesity and Polypharmacy among African American Older Adults: Gender as the Moderator and Multimorbidity as the Mediator.
Assari S; Wisseh C; Bazargan M
Int J Environ Res Public Health; 2019 Jun; 16(12):. PubMed ID: 31226752
[TBL] [Abstract][Full Text] [Related]
16. The delicate choice of optimal basic therapy for multimorbid older adults: A cross-sectional survey.
Sirois C; Lunghi C; Laroche ML; Maheux A; Frini A
Res Social Adm Pharm; 2019 Jun; 15(6):761-766. PubMed ID: 30249377
[TBL] [Abstract][Full Text] [Related]
17. Coexisting chronic conditions in the older population: Variation by health indicators.
Marengoni A; Angleman S; Meinow B; Santoni G; Mangialasche F; Rizzuto D; Fastbom J; Melis R; Parker M; Johnell K; Fratiglioni L
Eur J Intern Med; 2016 Jun; 31():29-34. PubMed ID: 26944564
[TBL] [Abstract][Full Text] [Related]
18. Multimorbidity in Māori and Pacific patients: cross-sectional study in a Dunedin general practice.
Stokes T; Azam M; Noble FD
J Prim Health Care; 2018 Mar; 10(1):39-43. PubMed ID: 30068450
[TBL] [Abstract][Full Text] [Related]
19. Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?
Calderón-Larrañaga A; Poblador-Plou B; González-Rubio F; Gimeno-Feliu LA; Abad-Díez JM; Prados-Torres A
Br J Gen Pract; 2012 Dec; 62(605):e821-6. PubMed ID: 23211262
[TBL] [Abstract][Full Text] [Related]
20. Psychosocial factors associated with medication burden among community-dwelling older people with multimorbidity.
Yang C; Zhu S; Hui Z; Mo Y
BMC Geriatr; 2023 Nov; 23(1):741. PubMed ID: 37964196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
